Further statistical analysis showed that higher serum CTLA-4 levels are associated with small tumor size (P < 0.001; Fig. 1b), absence of tumor necrosis (P < 0.001; Fig. 1c), and non-basal status (P = 0.002; Fig. 1d). Here, CTLA4 is linked to neoplasm.